Henry Gosebruch
Vorstandsvorsitzender bei NEUMORA THERAPEUTICS, INC.
Vermögen: 5 Mio $ am 31.12.2023
Profil
Henry O.
Gosebruch is currently the President, Chief Executive Officer & Director at Neumora Therapeutics, Inc. and an Independent Director at ACELYRIN, Inc. Previously, he served as an Independent Director at Aptinyx, Inc. from 2019 to 2023.
Prior to that, he was the Co-Head-Mergers & Acquisitions North America at JPMorgan Securities LLC in 2015.
From 2015 to 2023, he held the position of Chief Strategy Officer & Executive Vice President at AbbVie, Inc. Mr. Gosebruch obtained his undergraduate degree from The Wharton School of the University of Pennsylvania in 1995.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2024 | 524 793 ( 0,33% ) | 5 Mio $ | 30.04.2024 | |
ACELYRIN, INC.
0,05% | 09.05.2023 | 50 000 ( 0,05% ) | 212 000 $ | 30.04.2024 |
APTINYX INC
0,18% | 24.04.2023 | 125 000 ( 0,18% ) | 12 000 $ | 31.12.2023 |
Aktive Positionen von Henry Gosebruch
| Unternehmen | Position | Beginn |
|---|---|---|
| ACELYRIN, INC. | Direktor/Vorstandsmitglied | 29.03.2023 |
| NEUMORA THERAPEUTICS, INC. | Vorstandsvorsitzender | 18.07.2023 |
Ehemalige bekannte Positionen von Henry Gosebruch
| Unternehmen | Position | Ende |
|---|---|---|
| APTINYX | Direktor/Vorstandsmitglied | 04.05.2023 |
| ABBVIE INC. | Corporate Officer/Principal | 01.02.2023 |
JPMorgan Securities LLC
 JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Corporate Officer/Principal | 01.12.2015 |
Ausbildung von Henry Gosebruch
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| ABBVIE INC. | Health Technology |
| APTINYX | Health Technology |
| ACELYRIN, INC. | Health Technology |
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
JPMorgan Securities LLC
JPMorgan Securities LLC Investment Banks/BrokersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Finance |